Loading...
XKRX
001795
Market cap180mUSD
Oct 08, Last price  
2,110.00KRW
1D
-1.40%
1Q
-1.40%
Jan 2017
69.48%
Name

TS Corp

Chart & performance

D1W1MN
XKRX:001795 chart
P/E
—
P/S
0.13
EPS
—
Div yield, %
5.92%
Shrs. gr., 5y
1.15%
Rev. gr., 5y
2.23%
Revenues
1.36t
-1.28%
1,128,086,412,0001,424,430,338,0001,295,924,682,0001,303,527,893,0001,402,142,901,0001,480,336,998,0001,359,908,602,0001,323,531,308,0001,308,210,047,0001,264,247,251,0001,274,536,938,0001,210,088,269,0001,204,394,671,0001,214,452,231,0001,261,349,333,0001,378,075,519,0001,332,349,884,0001,373,829,105,0001,356,276,028,000
Net income
-60.25b
L
11,119,529,0005,444,095,00022,718,537,00013,338,359,00019,085,446,00029,181,302,00010,740,301,0006,516,848,000-17,639,257,00022,542,368,00010,606,310,0009,729,575,00011,538,266,00022,611,448,00020,172,602,00025,543,443,00032,573,495,00020,491,028,000-60,247,447,000
CFO
-8.60b
L
-6,956,253,000-37,904,117,00018,250,305,00016,078,696,0002,617,464,000-27,344,396,000105,713,482,000-12,338,169,000-7,328,788,00086,912,335,00010,536,903,00012,613,990,0008,509,710,00064,757,973,000-11,839,308,00011,398,287,00040,029,747,00050,352,405,000-8,598,230,000
Dividend
Dec 29, 2025125 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1956 and headquartered in Seoul, South Korea, TS Corporation is a diverse enterprise primarily focused on the food industry. Its main activities involve the manufacturing and distribution of a wide range of food products, such as sugar, various foodstuffs, food ingredients, additives, dairy items, raw materials for baking, mixed seasonings, and other agricultural goods. In addition to its food-related business, the company trades in non-ferrous metals. TS Corporation also serves the agricultural sector by providing animal feed, including livestock feed sold under the 'Rainbow' brand. It offers administrative support services, featuring digital tools designed for farm management optimization, and delivers pathology laboratory services that comprise extensive testing, analysis, and diagnostic examinations for agricultural producers. Furthermore, the company ventures into biotechnology, concentrating on the development of nutraceuticals and premium food products engineered to combat aging and mitigate adult diseases. Simultaneously, it undertakes the research, production, and commercialization of two significant biological products: erythropoietin and streptokinase. With a global reach, its products are exported to various international markets, including China, Southeast Asia, and Micronesia.

Key people

Hyeon Cho
Co-Chief Executive Officer, Director · since 2017
Yeong Gwon Kim
Co-Chief Executive Officer, Director · since 2017
Chu Heon Lee
Vice Chairman · since 2012
Seung Jun Nah
Vice President
Gang Hwan Lee
Managing Director
Chang Geun Yang
Managing Director
Geun Hoe Kim
Assistant Managing Director
Wu Sik Lee
Internal Auditor · since 2013
Eun Sik Park
Assistant Managing Director
Dong Hwa Shin
Internal Auditor
Chun Gyu Yim
Assistant Managing Director
Geun Beom Yoo
Assistant Managing Director
Seung Wu Kang
Chief Executive Officer, Vice President, Director · since 2022
Hyo Seop Lee
Director
Mu Seong Lee
Non-Executive Independent Director · since 2012
Sang Wuk Lee
Non-Executive Independent Director · since 2008
IPO date
Dec 27, 1968
Employees
Domiciled in
KR
Incorporated in
KR
Headquarters & legal address
인천광역시 중구 월미로 116 (북성동1가)
대한제당
Incheon Metropolitan City, 28 22300
KR
Address
116, Wolmi-ro, Jung-gu, Incheon
TS CORPORATION
Incheon Metropolitan City, 28 22300
KR
Other language
TS CORPORATION

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT